Matches in Wikidata for { <http://www.wikidata.org/entity/Q61713093> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q61713093 description "assaig clínic" @default.
- Q61713093 description "clinical trial" @default.
- Q61713093 description "clinical trial" @default.
- Q61713093 description "clinical trial" @default.
- Q61713093 description "clinical trial" @default.
- Q61713093 description "ensaio clínico" @default.
- Q61713093 description "ensayo clínico" @default.
- Q61713093 description "ensayu clínicu" @default.
- Q61713093 description "essai clinique" @default.
- Q61713093 description "klinisch onderzoek" @default.
- Q61713093 description "клінічне випробування" @default.
- Q61713093 description "կլինիկական փորձարկում" @default.
- Q61713093 name "Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 Patients" @default.
- Q61713093 name "Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 Patients" @default.
- Q61713093 type Item @default.
- Q61713093 label "Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 Patients" @default.
- Q61713093 label "Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 Patients" @default.
- Q61713093 prefLabel "Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 Patients" @default.
- Q61713093 prefLabel "Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 Patients" @default.
- Q61713093 P1050 Q61713093-1D3B3DD6-4016-436B-90F1-7962318BB474 @default.
- Q61713093 P1132 Q61713093-C15B0222-6034-4BA7-A492-B4852249FD16 @default.
- Q61713093 P1476 Q61713093-6F8F0233-B197-44D6-8169-463CC8E5619F @default.
- Q61713093 P17 Q61713093-65B60914-CD4F-4AB1-9FAB-65C6765A1D4E @default.
- Q61713093 P17 Q61713093-90F06B9C-8767-4204-8291-616E153E8CBB @default.
- Q61713093 P17 Q61713093-9143196C-525F-4FDA-85D5-7F7174DBF0DA @default.
- Q61713093 P2899 Q61713093-55D50966-562C-492D-A3DE-541672CF70BA @default.
- Q61713093 P3098 Q61713093-C0DED1D1-917D-41AC-B65B-7218AECD42D2 @default.
- Q61713093 P31 Q61713093-955FED71-C2AD-4081-ACF9-B63D91ABFEED @default.
- Q61713093 P4135 Q61713093-CA243EF3-BD48-49A7-B036-2EFDE13BFC34 @default.
- Q61713093 P4844 Q61713093-D67B2D92-6ABC-4CF8-BF02-5CEE9E63ED11 @default.
- Q61713093 P4844 Q61713093-D79F82E0-321B-47E4-A826-29597B2AE13E @default.
- Q61713093 P580 Q61713093-B31E576F-1561-4EA7-9CEF-82EEDF4247F8 @default.
- Q61713093 P582 Q61713093-68FD9F26-717A-4C4F-9317-09F266CFDAAB @default.
- Q61713093 P6099 Q61713093-7688999C-23C5-44FF-81B1-793BA396506B @default.
- Q61713093 P8363 Q61713093-431F11BF-C8D8-411E-A7DA-61FC0B43116E @default.
- Q61713093 P859 Q61713093-B25200D7-C276-4688-9C80-69340B4DA69F @default.
- Q61713093 P1050 Q12206 @default.
- Q61713093 P1132 "+876" @default.
- Q61713093 P1476 "A Phase III Randomised, Double-blind, Double-dummy, Parallel Group Study to Compare the Efficacy and Safety of Twice Daily Administration of the Fix Dose Combination of Linagliptin 2.5 mg + Metformin 500 mg, or of Linagliptin 2.5 mg + Metformin 1000 mg, With the Individual Components of Metformin (500 mg or 1000 mg, Twice Daily), and Linagliptin (5.0 mg, Once Daily) Over 24 Weeks in Treatment naïve Type 2 Diabetic Patients With Insufficient Glycaemic Control" @default.
- Q61713093 P17 Q833 @default.
- Q61713093 P17 Q881 @default.
- Q61713093 P17 Q928 @default.
- Q61713093 P2899 "+18" @default.
- Q61713093 P3098 "NCT01708902" @default.
- Q61713093 P31 Q30612 @default.
- Q61713093 P4135 "+80" @default.
- Q61713093 P4844 Q19484 @default.
- Q61713093 P4844 Q909745 @default.
- Q61713093 P580 "2012-10-01T00:00:00Z" @default.
- Q61713093 P582 "2014-04-01T00:00:00Z" @default.
- Q61713093 P6099 Q42824827 @default.
- Q61713093 P8363 Q78089383 @default.
- Q61713093 P859 Q699532 @default.